Trimetazidine Improves the Outcome of EECP Therapy in Patients with Refractory Angina Pectoris.

Med Arch · 2020 · PMC7406001 · PMID 32801436

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

highly significantP<0.05actually significant

Also, we found in the TMZ-EECP group, there was a highly significant decrease (P<0.05) in the MCP-1 serum level in the post TMZ-EECP combination therapy in comparison with EECP-group (post-EECP therapy) and these results shown in Figure 2 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.